This inventor holds 1 USPTO granted patent. Top assignee: E. R. Squibb Sons, Inc.. Active years: 1993.
Company Filing History:
Years Active: 1993
Title: Garry R Hodges: Innovator in Pharmaceutical Compositions
Introduction
Garry R Hodges is a notable inventor based in Merseyside, GB. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative approach to enteric coated compositions. His work has the potential to enhance the effectiveness of medications that are sensitive to acidic environments.
Latest Patents
Hodges holds a patent for an enteric coated pharmaceutical composition. This composition includes a medicament that is sensitive to a low pH environment of less than 3, such as pravastatin. The formulation is preferably in the form of pellets, which are coated with a mixture of neutralized hydroxypropylmethyl cellulose phthalate, plasticizer, and anti-adherent. The resulting pellets exhibit excellent resistance to deterioration at pH levels below 3 while maintaining effective drug release properties at pH levels above 3. He has 1 patent to his name.
Career Highlights
Hodges is associated with E. R. Squibb Sons, Inc., where he has been instrumental in developing innovative pharmaceutical solutions. His expertise in creating formulations that improve drug stability and release is highly regarded in the industry.
Collaborations
One of his notable collaborators is David L McCann. Their partnership has contributed to advancements in pharmaceutical compositions, enhancing the efficacy of various medications.
Conclusion
Garry R Hodges is a distinguished inventor whose work in enteric coated pharmaceutical compositions showcases his commitment to improving drug delivery systems. His contributions are valuable to the pharmaceutical industry and have the potential to benefit many patients.